Vetoquinol SA's latest marketcap:
As of 08/15/2025, Vetoquinol SA's market capitalization has reached $1.03 B. According to our data, Vetoquinol SA is the 9748th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.03 B |
| Revenue (ttm) | 630.27 M |
| Net Income (ttm) | 68.6 M |
| Shares Out | 11.8 M |
| EPS (ttm) | 5.82 |
| Forward PE | 14.67 |
| Ex-Dividend Date | 06/04/2025 |
| Earnings Date | 09/11/2025 |
Vetoquinol SA's yearly market capitalization.
| Date | Market Cap(€) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/15/2025 | €882.32 M | $1.03 B | -0.44% | 9748 |
| 12/31/2024 | €886.25 M | $917.47 M | -26.85% | 9264 |
| 12/29/2023 | €1.21 B | $1.34 B | 16.92% | 7231 |
| 12/30/2022 | €1.04 B | $1.11 B | -33.62% | 7773 |
| 12/31/2021 | €1.56 B | $1.77 B | 57.82% | 6624 |
| 12/31/2020 | €989.14 M | $1.21 B | 29.72% | 7132 |
| 12/31/2019 | €762.55 M | $855.04 M | 26.61% | 7516 |
| 12/31/2018 | €602.3 M | $690.6 M | -16.06% | 7549 |
| 12/29/2017 | €717.55 M | $860.63 M | 32.83% | 7825 |
| 12/30/2016 | €540.18 M | $568.06 M | 15.57% | 8988 |
Company Profile
About Vetoquinol SA
Vetoquinol SA is a leading veterinary pharmaceutical company specializing in the design, development, and sale of veterinary drugs and non-medicinal products. With a global presence, it operates across Europe, the Americas, and the Asia Pacific region.
Product Offerings
The company provides a wide range of veterinary solutions, including:
- Mobility, Pain, and Inflammation – Treatments for joint and musculoskeletal health.
- Dermatology, Hygiene, and Care – Products for skin and coat health.
- Anti-Parasite – Solutions for parasite control.
- Udder Health – Specialized treatments for dairy animals.
- Infectious Diseases – Vaccines and therapies for disease prevention.
- Reproduction – Fertility and breeding support.
- Behavior Management – Products to address behavioral issues.
- Internal Medicine – Treatments for digestive and metabolic conditions.
- Cardiology-Nephrology – Heart and kidney health solutions.
These products cater to a variety of animals, including cattle, sheep, pigs, poultry, dogs, cats, and horses.
Company Background
Founded in 1933, Vetoquinol SA is headquartered in Lure, France. It operates as a subsidiary of Soparfin SCA.
Frequently Asked Questions
-
What is Vetoquinol SA's (EPA-VETO) current market cap?As of 08/15/2025, Vetoquinol SA (including the parent company, if applicable) has an estimated market capitalization of $1.03 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Vetoquinol SA (EPA-VETO) rank globally by market cap?Vetoquinol SA global market capitalization ranking is approximately 9748 as of 08/15/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.